3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Hyperphosphatemia: new trials by email Literature Review of Hyperphosphatemia trials Research Report on Hyperphosphatemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phosphate in Acute Pancreatitis Sodium Phosphate, Potassium Phosphate - Pancreatitis | Phase 2 | Recruiting | Duke University | 100 | 2026-07-09 | 2026-08-26 |
| A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia AP306 75 mg BID, AP306 125 mg BID, AP306 150 mg BID - Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 2 | Recruiting | R1 Therapeutics | 168 | 2026-06-01 | 2026-08-26 |
| Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia JMKX003002 will be administered orally, Sevelamer carbonate - Hyperphosphatemia | Phase 2 | Recruiting | Jemincare | 50 | 2024-12-30 | 2025-02-03 |
Hypophosphatemia (1) · Pancreatitis (1)
Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Phosphorus Metabolism Disorders (3) · Digestive System Diseases (1) · Pancreatic Diseases (1)
BID protein, human (1) · Sevelamer (1) · potassium phosphate (1) · sodium phosphate (1)
Duke University (1) · Jemincare (1) · R1 Therapeutics (1)
China (2) · United States (2)
R01DK142980 (1)